Archives
-
Capecitabine and the Tumor–Stroma Response
2026-09-21
Capecitabine offers translational researchers more than a fluoropyrimidine prodrug: its activation biology can expose how tumor–stroma interactions reshape chemotherapy response. Patient-derived gastric assembloids provide a practical framework for testing that hypothesis.
-
HotStart 2X Green qPCR Master Mix for Epigenetics
2026-09-21
Discover how HotStart 2X Green qPCR Master Mix can support targeted validation of RNA-seq findings in histone-acetylation and spermatogenesis research. This article connects assay chemistry with biological interpretation, helping researchers distinguish transcript changes from altered cell composition and protein-level phenotypes.
-
Proximity Labeling Tracks Synaptic Protein Trafficking
2026-09-20
Pascual-Caro and de Juan-Sanz developed a synaptic-cleft proximity-labeling strategy that captures endogenous proteins transiently exposed during synaptic vesicle exocytosis. By matching the biotinylation pulse to rapid vesicle cycling, the method enables activity-dependent proteomic analysis and provides direct evidence for trafficking of ATG9A and NPTX1.
-
NET-DNA–CCDC25 Control of ILC3 Repair
2026-09-19
A 2026 FASEB Journal study identifies a mechanistic link between neutrophil extracellular trap DNA, CCDC25 signaling in ILC3s, and impaired intestinal epithelial repair in ulcerative colitis models. Its combination of genetic, enzymatic, cellular, and epithelial-barrier experiments suggests that NET-DNA-driven suppression of IL-22 is an important contributor to mucosal injury.
-
Biotin-HPDP for S-Nitrosylation Assays
2026-09-18
Biotin-HPDP enables reversible thiol-specific protein labeling for investigating S-nitrosylation. This article develops an assay-design framework around STOP1 and STAR1 regulation during Arabidopsis aluminum stress, emphasizing controls, interpretation, and reversible enrichment.
-
TGF-β, Sca-1, and Mammary Cell Plasticity
2026-09-18
The reference study shows that TGF-β signaling dynamically regulates Sca-1 expression, lineage plasticity, and tumor-initiating behavior in pre-neoplastic and mammary cancer cell models. Its combination of comparative cell systems, pathway perturbation, and functional analysis clarifies why Sca-1 should be interpreted as a state-dependent marker rather than a fixed definition of stemness.
-
CTP Solution (100 mM) for Reliable RNA Workflows
2026-09-17
This scenario-driven guide explains how CTP Solution (100 mM), SKU K1045, supports controlled in vitro transcription and RNA amplification workflows that feed cell proliferation, viability, and cytotoxicity studies. It connects defined nucleotide handling with recent preclinical p21 mRNA-LNP research while separating product specifications from workflow recommendations.
-
Glabridin–Gold(I) Complex Reprograms Antitumor Immunity
2026-09-17
The reference study develops complex 6d, which combines an N-heterocyclic carbene gold(I) center with glabridin to inhibit TrxR and modulate MAPK signaling. In liver cancer models, this dual activity increases tumor immunogenicity while reducing immunosuppressive immune populations, providing a mechanistic rationale for combining redox-directed metal complexes with cancer immunotherapy.
-
Diclofenac: Non-Selective COX Inhibitor Guide
2026-09-16
Diclofenac is a non-selective COX inhibitor used to reduce prostaglandin production in inflammation and pain signaling research. This guide connects its biochemical activity with human pluripotent stem cell-derived intestinal organoid models while defining solvent, storage, assay, and interpretation limits.
-
5-Methyl-CTP: From Transcript Design to Translation
2026-09-16
A translational framework for using 5-Methyl-CTP to improve mRNA design while recognizing that transcript chemistry, delivery, antigen presentation, and experimental validation must be optimized as one system.
-
Patient-Derived Gastric Cancer Assembloids
2026-09-15
A 2025 study developed patient-derived gastric cancer assembloids by combining matched tumor organoids with tumor-derived stromal subpopulations, including fibroblasts, mesenchymal stem cells, and endothelial cells. The model altered gene-expression programs and drug responses relative to monocultures, providing a more physiologically relevant platform for studying tumor–stroma interactions, resistance, and personalized treatment strategies.
-
Masitinib (AB1010): KIT/PDGFR Workflow Guide
2026-09-15
Masitinib (AB1010) provides a DMSO-compatible way to investigate KIT and PDGFRα/β inhibition in cancer biology, mastocytosis research, and inflammatory cell models. It is not suitable for aqueous or ethanol-based workflows, broad-spectrum kinase profiling, or direct clinical treatment conclusions.
-
RSV NS3 Phosphorylation Rewires Host Signaling
2026-09-14
Zhuang et al. show that Rice stripe virus NS3 changes function during infection by interacting with and being phosphorylated through the OsSnRK3.25 pathway. This stage-dependent control links antiviral RNA interference, reactive oxygen species, programmed cell death, pathogenicity, and vector transmission in a co-survival model spanning rice and the planthopper vector.
-
Epacadostat Workflow for IDO1 Immunometabolism
2026-09-14
Epacadostat (INCB024360) enables a practical bridge between IDO1 biochemistry, standardized whole-blood stimulation, and tumor-immune modeling. This workflow emphasizes solvent control, orthogonal metabolic readouts, donor-aware cytokine analysis, and rational PD-1/PD-L1 checkpoint inhibitor combination testing.
-
Protease Inhibitor Cocktail for Plant Extracts
2026-09-13
Protect fragile plant proteins during extraction, immunoblotting, co-immunoprecipitation, and kinase assays with broad-spectrum, EDTA-free inhibition. This workflow connects better protein preservation to mechanistic studies of NSP2–MYB40 control of flavonoid biosynthesis and symbiotic signaling.